Status:
COMPLETED
Peripheral Muscle Function in Patients With COPD
Lead Sponsor:
Fondazione Don Carlo Gnocchi Onlus
Conditions:
Copd
Eligibility:
All Genders
35-85 years
Brief Summary
Chronic obstructive pulmonary disease (COPD) is characterized by irreversible airway obstruction and progressive deterioration of respiratory function. Patients with COPD show a limited exercise toler...
Eligibility Criteria
Inclusion
- COPD diagnosis (GOLD stage: II-III-IV), defined as post-bronchodilator forced expiratory volume in 1s (FEV1)/forced vital capacity \< 0.7 and FEV1 \< 80% predicted.
Exclusion
- Restrictive lung disease, unstable conditions, recent exacerbation, infection, embolism, pneumothorax, thoracic or abdominal surgery (less than 3 months before recruitment).
- Cardiologic conditions like myocardial infarction (less than 6 months before recruitment), heart failure, or severe angina.
- Inability of perform the exercise training (e.g. orthopaedic conditions).
- Incapability to understand the instructions required to carry out the tests and assessments planned.
Key Trial Info
Start Date :
January 13 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04767126
Start Date
January 13 2021
End Date
November 30 2021
Last Update
March 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Fondazione Don Carlo Gnocchi
Milan, Italy, 20100